Ralph Hall
Prof. Hall Quoted in FDAnews Article on FDA 510(k) Risk/Benefit Reviews
Professor Ralph Hall was quoted in an FDAnews article entitled "FDA Details 510(k) Risk/Benefit Reviews; Expert Calls New Process Burdensome" by Elizabeth Orr. Click here to read the full article.